ArticleJournal of orthopaedic surgery and research2025
Effectiveness of a super-oxidized solution for decontaminating ACL grafts: a prospective study.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccidental contamination of anterior cruciate ligament (ACL) grafts during surgery is a relatively unexplored issue. This study aims to evaluate bacterial contamination in ACL grafts and the effectiveness of Microdacyn® in reducing contamination. The species of bacteria present on contaminated grafts and their antibiotic susceptibility were also analyzed.
methodsA total of 70 patients undergoing ACL reconstruction between 2019 and 2022 were included. Patients with prior knee surgery or immunodeficiency were excluded. Grafts were divided into three groups: (1) control (kept sterile), (2) contaminated (dropped on the operating room floor), and (3) rinsed (dropped and then decontaminated in Microdacyn®). Bacteriological examination and drug sensitivity tests were performed on all grafts. Statistical analysis was conducted using chi-square tests.
resultsGrafts dropped on the floor showed a 74.3% (52 out of 70) contamination rate, with Staphylococcus epidermidis being the most commonly observed bacteria. After decontamination with Microdacyn®, 65.7% (46 out of 70) of the grafts were found sterile. The most sensitive antibiotics were trimethoprim + sulfamethoxazole, aztreonam and ceftazidime (97% effectiveness), while vancomycin, gentamicin, and meropenem were 95-96% effective.
conclusionsWhile Microdacyn® reduced bacterial contamination, a significant portion of grafts remained contaminated, indicating that it is not fully effective. However, the bacteria found on the grafts showed high susceptibility to simple and inexpensive antibiotics, which did not contribute to increased resistance. Further studies exploring alternative decontamination methods are recommended to reduce the risk of complications from graft contamination during ACL reconstruction. LEVEL OF EVIDENCE: II.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.